|
|
News Breaks | | | | November 13, 2012 | | 16:12 EDT |  | HSKA | Heska reports Q3 EPS (1c), consensus 8c
Reports Q3 revenue $16.9M, consensus $19.7M. The company said, "The third quarter was impacted by softness with our SoloStep Heartworm product. Much of this weakness was due to aggressive market pricing by our competitors, but we believe the unusually warm summer encouraged certain veterinarians to use solutions that included other tests, such as Lyme Disease." | |
|
News For HSKA From The Last 14 Days Check below for free stories on HSKA the last two weeks. |
|
|
| May 14, 2013 | | 16:16 EDT | | HSKA | Heska reports Q1 EPS (7c), consensus 12c
 Subscribe for More Information | |
|
|
|
|
|
|
